Global X S&P Biotech ETF
CURE
- A$62.00
- 0.94
- 1.49%
Global X S&P Biotech ETF CURE Strategy
The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
ETFs News & Analysis
etfs
Silver rated global value ETF
Low-cost and efficient access to international equities with a strong value tilt.
etfs
Young & Invested: The illusion of ETF returns
Finding false comfort in recent winners overlooks an important signal of fund quality.
etfs
A Bitcoin ETF doubled in value. Its investors made only one-fourth of that
iShares Bitcoin Trust ETF gained over 46% per year since inception, but the average dollar made only 11% annually.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,018.80 | 0.80 | -0.01% |
| CAC 40 | 8,149.50 | 18.65 | -0.23% |
| DAX 40 | 24,490.41 | 139.29 | 0.57% |
| Dow JONES (US) | 48,209.01 | 158.05 | -0.33% |
| FTSE 100 | 9,931.38 | 9.33 | -0.09% |
| HKSE | 25,630.54 | 224.06 | -0.87% |
| NASDAQ | 23,358.45 | 60.63 | -0.26% |
| Nikkei 225 | 50,339.48 | 187.44 | -0.37% |
| NZX 50 Index | 13,548.42 | 0.29 | 0.00% |
| S&P 500 | 6,876.22 | 20.02 | -0.29% |
| S&P/ASX 200 | 8,714.30 | 0.50 | -0.01% |
| SSE Composite Index | 3,968.84 | 3.72 | 0.09% |